Aspire Private Capital »

Seelos Therapeutics Ord shares owned by Aspire Private Capital

Quarter-by-quarter ownership of Seelos Therapeutics Ord (SEEL) shares owned by Aspire Private Capital from 13F filings

Historical chart of Aspire Private Capital investment in Seelos Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics Ord held by Aspire Private Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics Ord by Aspire Private Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $30 50 0.60
2023-12-31 $69 50 1.38

More positions owned by Aspire Private Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ssga Active Tr Spdr Ssga Fxd (FISR)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Value Etf (VTV)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Ssga Active Tr Spdr Ssga Us Sct (XLSR)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Ser Tr Bloomberg High Y (JNK)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Spdr Ser Tr Portfolio S&p600 (SPSM)

View all positions for Aspire Private Capital

Top funds holding Seelos Therapeutics Ord

Wealth Effects
AdvisorShares Investments
Jeffrey L. Gendell
Balyasny Asset Management
Vanguard Group
Modera Wealth Management
Morgan Stanley
Geode Capital Management
BlackRock
Strategic Family Wealth Counselors
Jane Street
XTX Topco
Two Sigma Investments
CRA Financial Services
Tower Research Capital

View all funds holding Seelos Therapeutics Ord